Hostname: page-component-cd9895bd7-p9bg8 Total loading time: 0 Render date: 2024-12-23T00:00:31.767Z Has data issue: false hasContentIssue false

Young Biomedical Scientists: Undervalued and Overabundant

Published online by Cambridge University Press:  17 May 2016

John T. Finn*
Affiliation:
The Washington Institute, USA
*
Correspondence should be addressed to the Washington Institute, 6850 Elm Street, McLean, VA22101-3821, USA (E-mail: [email protected]).
Get access

Extract

Biomedical research is a success by any standard. It has led to treatments and preventive practices that have caused rates of death from the major killers—heart disease, cancer, and stroke—to decline steadily over the past few decades (National Center for Health Statistics, 2002: Table 30). Hundreds of new drugs have been approved over the past decade (U.S. Food and Drug Administration, 2002), and another 1000 potential drugs are under development (Pharmaceutical Research and Manufacturers of America, 2002). The past year alone has seen breakthroughs in understanding afflictions as diverse as sickle cell anemia, tuberculosis, breast cancer, Alzheimer's disease, depression, and substance abuse.

Type
Commentary
Copyright
Copyright © Association for Politics and the Life Sciences 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Cohen, M.L. (2000). “Changing Patterns of Infectious Disease.” Nature 406:762–7.Google Scholar
Freeman, R., Weinstein, E., Marincola, E., Rosenbaum, J. and Solomon, F. (2001). “Competition and Careers in Biosciences.” Science 294:2293–4.CrossRefGoogle Scholar
Gratz, N.G. (1999). “Emerging and Resurging Vector-Borne Diseases.” Annual Review of Entomology 44:5175.Google Scholar
Holden, C. (1998). “Report Paints Grim Outlook for Young Ph.D.s.” Science 281:1584.CrossRefGoogle Scholar
National Academy of Sciences, Committee on Science, Engineering, and Public Policy (2000). Enhancing the Postdoctoral Experience for Scientists and Engineers. Washington, DC: National Academy Press.Google Scholar
National Center for Health Statistics (2002). Health, United States, 2002. Washington, DC: U.S. Department of Health and Human Services. Available athttp://www.cdc.gov/nchs/hus.htm.Google Scholar
National Institutes of Health (2003). NIH Guide to Grants and Contracts 2003. Bethesda, MD: National Institutes of Health. Available athttp://grants.nih.gov/grants/guide.Google Scholar
National Research Council, Committee on Dimensions, Causes, and Implications of Recent Trends in the Careers of Life Scientists (1998). Trends in the Early Careers of Life Scientists. Washington, DC: National Academy Press.Google Scholar
National Research Council, Committee on National Needs for Biomedical and Behavioral Scientists (2000). Addressing the Nation's Changing Needs for Biomedical and Behavioral Scientists. Washington, DC: National Academy Press.Google Scholar
Pharmaceutical Research and Manufacturers of America (2002). PHRMA Annual Report 2002–2003. Washington, DC: Pharmaceutical Research and Manufacturers of America. Available athttp://www.phrma.org/publications/publications/15.12.2002.830.cfm.Google Scholar
Regets, M.C. (1998). “Has the Use of Postdocs Changed?” National Science Foundation issue brief 99–310. Arlington, VA: National Science Foundation, Division of Science Resources Statistics. Available athttp://www.nsf.gov/sbe/srs/issuebrf/ib99310.htm.Google Scholar
Schmidt, K. (1999). “Will the Job Market Ever Get Better?” Science 285:1517–9.Google Scholar
U.S. Food and Drug Administration (2002). Center for Drug Evaluation and Research 2002 Report to the Nation: Improving Public Health Through Human Drugs. Washington, DC: U.S. Department of Health and Human Services. Available athttp://www.fda.gov/cder/reports/rtn/2002/rtn2002.htm.Google Scholar
Vogel, G. (1999). “A Day in the Life of a Topflight Lab.” Science 285:1531–2.CrossRefGoogle Scholar
World Health Organization (2003). Communicable Diseases 2002: Global Defence Against the Infectious Disease Threat. Kindhauser, M.K., ed. Geneva, Switzerland: World Health Organization. Available athttp://www.who.int/pub/en.Google Scholar
Zumeta, W. and Raveling, J.S. (2002). The Washington, DC: Commission on Professionals in Science and Technology. Available athttp://www.cpst.org.Google Scholar
Zumeta, W. and Raveling, J.S. (2003). “Attracting the Best and the Brightest.” Issues in Science and Technology Winter 2002–03: 3640.Google Scholar